Pemphigus vulgaris: Benefits of tetracycline as adjuvant therapy in a series of thirteen patients

International Journal of Dermatology

Volumn 38, Issue 3, 1999, Pages 217-221

  Calebotta, Adriana ^a   Sáenz, Ana María ^a,b   Gonzalez, Francisco ^a   Carvalho, Marisol ^a   Castillo, Ricardo ^a  

^a HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

^b CCS 6140 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; PREDNISONE; TETRACYCLINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; HOSPITALIZATION; HUMAN; MALE; PEMPHIGUS VULGARIS;

ADULT; ANTI-BACTERIAL AGENTS; AZATHIOPRINE; CHEMOTHERAPY, ADJUVANT; DRUG THERAPY, COMBINATION; FEMALE; GASTROINTESTINAL DISEASES; GLUCOCORTICOIDS; HOSPITALIZATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PEMPHIGUS; PREDNISONE; SEVERITY OF ILLNESS INDEX; SKIN; TETRACYCLINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0032891858     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1999.00624.x     Document Type: Article

References (37)

1. Becker BA, Gaspari AA. Pemphigus vulgaris and vegetans. Dermatol Clin 1993; 11(3): 429-452.
2. Provost T. Pemphigus (Editorial). N Engl J Med 1982; 306: 1124-1215.
3. Stanley JR. Pemphigus. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al. eds. Dermatology in General Medicine, 4th edn. New York: McGraw-Hill, 1993: 606-615.
4. Pye RJ. Bullous eruption. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology, 5th edn. London: Blackwell Scientific Publications, 1993: 1638-1647.
5. Calebotta A. Pénfigo, dermatitis herpetiforme, penfigoide: estudio estadistico restrospectivo en 60 pacientes del Hospital Universitario de Caracas. Morbilidad y Mortalidad Nacional 1958-1980. Dermatol Venez 1986; 24: 119-120.
6. Gellis S, Glass F. Pemphigus: a survey of one hundred and seventy patients admitted to Bellevue Hospital from 1911 to 1941. Arch Dermatol 1941; 44: 321-336.
7. Savin JA. International mortality from bullous diseases since 1950. Br J Dermatol 1976; 94: 179-189.
8. Razzaque Ahmed A, Moy R. Death in pemphigus. J Am Acad Dermatol 1982; 7: 221-228.
9. Krain LS. Pemphigus: epidemiologic and survival characteristics of 59 patients 1955-1973. Arch Dermatol 1974; 110: 862-865.
10. Rosenberg FR, Sanders S, Nelson CT. Pemphigus: a 20-year review of 107 patients treated with corticosteroids. Arch Dermatol 1976; 112: 962-970.
11. Mourellou O, Chaidemenos GC, Koussidou T, Kapetis E. The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11-year period. Br J Dermatol 1995; 133: 83-87.
12. Rico MJ. Treatment of autoimmune blistering diseases. Cutis 1993; 52: 357-361.
13. Fivenson D. Non-steroidal alternatives in treating the immunodermatoses. Proceedings of the 53rd Annual Meeting of the American Academy of Dermatology, February 4-9, 1995, New Orleans (Louisiana), USA.
14. Allan Berk M, Lorinez AL. The treatment of bullous pemphigus with tetracycline and nicotinamide. Arch Dermatol 1986; 122: 670-674.
15. Thornfeldt CR, Menkes AW. Bullous pemphigoid controlled by tetracycline. J Am Acad Dermatol 1987; 16: 305-310.
16. Peoples D, Fivenson DP. Linear IgA bullous dermatosis: successful treatment with tetracycline and nicotinamide. J Am Acad Dermatol 1992; 26: 498-499.
17. Fivenson DP, Breneman DL, Rosen GB, et al. Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol 1994; 130: 753-758.
18. Chaffins ML, Collison D, Fivenson DP. Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13 cases. J Am Acad Dermatol 1993; 28: 998-1000.
19. Carson PJ, Hameed A, Ahmed AR. Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol 1996; 34: 645-652.
20. Humbert P, Treffel P, Chapuis JF, et al. The tetracyclines in dermatology. J Am Acad Dermatol 1991; 25: 691-697.
21. Hoeprich PD, Martin CH. Effect of tetracycline, polymyxin B and rifampicin on phagocytosis. Clin Pharmacol Ther 1970; II: 418-422.
22. Russell Martin R, Warr GA, Couch RB, et al. Effects of tetracycline on leucotaxis. J Infect Dis 1974; 129: 110-115.
23. Gnarpe H, Leslie D. Tetracycline and host defense mechanism. Doxycycline interference with phagocytosis of Escherichia coli. Microbiog 1974; 10A: 127-138.
24. Thong YH, Ferrante A. Inhibition of mitogen-induced human lymphocyte proliferative responses by tetracycline analogues. Clin Exp Immunol 1979; 35: 443-446.
25. Gaspar ZS, Walkden V, Wojnarowska F. Minoycline is a useful adjuvant therapy for pemphigus. Australas J Dermatol 1996; 37: 93-95.
26. Zackheim HS, Vasily DB, Westphal ML, Hasting Ch.W. Reactions to niacinamide (letter). J Am Acad Dermatol 1981; 4: 736-737.
27. Zillikens D, Ambach A, Zenter A, et al. Evidence for cell-mediated immune mechanisms in the pathology of pemphigus. Br J Dermatol 1993; 128: 636-643.
28. Najar I, Oberti J, Teyssier J. Kinetics of the uptake of rifampicin and tetracycline into mouse macrophages. Pathol Biol 1984; 32: 85-89.
29. Esterly NB, Furey NL, Flanagan LE. The effect of antimicrobial agents on leukocyte chemotaxis. J Invest Dermatol 1978; 70: 51-55.
30. 4-induced intraepidermal accumulation of polymorphonuclear leukocytes. Acta Derm Venereol (Stockh) 1990; 70: 46-48.
31. Webster GF, Toso SM, Hegemann L. Inhibition of a model of in vitro granuloma formation by tetracycline and ciprofloxacin. Arch Dermatol 1994; 130: 748-752.
32. Elewski BE, Lamb BAJ, Sams WM, Gammon WR. In vivo suppression of neutrophil chemotaxis by systemically and topically administered tetracycline. J Am Acad Dermatol 1983; 8: 807-812.
33. Banck G, Forsgren A. Antibiotics and suppression of lymphocyte function in vitro. Antimicrob Agents Chemother 1979; 16: 524-560.
34. Forsgren A, Gnarpe H. Tetracycline interference with the bactericidal effect of serum. Nature New Biol 1973; 244: 82-83.
35. Eady AE, Ingham E, Walters Ch.E, et al. Modulation of comedonal levels of interleukin-1 in acne patients treated with tetracycline. J Invest Dermatol 1993; 101: 86-91.
36. Aberer W, Wolffk-Schreiner EC, Stingl G, Wolff K. Azathioprine in the treatment of pemphigus vulgaris. J Am Acad Dermatol 1987; 16: 527-533.
37. Younger IR, Harris DWS, Colver GB. Azathioprine in dermatology. J Am Acad Dermatol 1991; 25: 281-286.